Evaluating the outcomes of temporal bone resection in metastatic cutaneous head and neck malignancies: 13-year review.
OBJECTIVE
To evaluate the survival outcomes of patients who underwent lateral temporal bone resection as treatment for metastatic skin cancers.


METHODS
A single-institute, retrospective chart review was carried out on patients who underwent lateral temporal bone resection between January 2000 and December 2012. Overall survival and disease-free survival rates were calculated.


RESULTS
Forty-seven patients underwent temporal bone resection for primary (n = 21) or recurrent (n = 26) malignancies. The majority of patients (95.4 per cent) had advanced disease (stage III or IV). Average patient follow-up duration was 45 months. The 5-year and 10-year overall survival rates were 40 per cent and 23 per cent respectively. The five-year disease-free survival rate was 28 per cent.


CONCLUSIONS
Aggressive initial surgical resection is warranted in the treatment of these tumours.
Department of Otolaryngology,St James Hospital,Dublin,Ireland.
A
A
O'Connor
Department of Epidemiology,University College Cork,Ireland.
L
L
Behan
Department of Pathology,St James Hospital,Dublin,Ireland.
M
M
Toner
Department of Otolaryngology,St James Hospital,Dublin,Ireland.
J
J
Kinsella
Department of Plastic Surgery,St James Hospital,Dublin,Ireland.
E
E
Beausang
Department of Otolaryngology,St James Hospital,Dublin,Ireland.
C
C
Timon
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000556:secondary / Q000601:surgery*; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000473:pathology*; D012888:Skull Neoplasms / Q000556:secondary / Q000601:surgery*; D013701:Temporal Bone / Q000601:surgery*
Carcinoma; Metastatic; Temporal Bone; Treatment Outcome